Frontlight ResearchEarly access
Trial site
Cancer hospital Fudan University
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 21 trial
- Phase 31 trial
- Phase 41 trial
- Status
- Completed3 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Fudan University2 trials
- Janssen Research & Development, LLC2 trials
- Sir Run Run Shaw Hospital1 trial
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.1 trial
Running trials
Recruiting
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
Recruiting
Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026